Clincosm LogoSign in Get a demo

Carcinoma, Non-Small-Cell Lung

Showing NaN - NaN of 59
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Japan, Korea, Republic of, United States (Gefitinib, MEDI4736)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Tampa, Florida
  • +6 more
Mar 22, 2022

NSCLC Trial in Worldwide (FKB238 (bevacizumab), Avastin (bevacizumab), Paclitaxel)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • FKB238 (bevacizumab)
  • +3 more
  • Fountain Valley, California
  • +146 more
Feb 25, 2022

NSCLC Trial in Seoul (Vactosertib 300 mg BID and pembrolizumab 200 mg IV)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Vactosertib 300 mg BID and pembrolizumab 200 mg IV
  • Seoul, Korea, Republic of
    Samsung Medical Center
Sep 22, 2021

NSCLC Trial in Worldwide (LY2875358, Erlotinib)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Herlev, Denmark
  • +41 more
Sep 2, 2021

NSCLC Trial in Seoul (CS-7017, Erlotinib)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Seoul, Songpa-Gu, Korea, Republic of
    Asan Medical Center
Apr 16, 2021

NSCLC Trial in Worldwide (Afatinib, pembrolizumab)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Lexington, Kentucky
  • +12 more
Feb 5, 2021

NSCLC Trial in Seoul (Durvalumab + doxorubicin + ifosfamide)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Durvalumab + doxorubicin + ifosfamide
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Nov 30, 2020

NSCLC Trial in Worldwide (Avelumab, Docetaxel)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Tuscaloosa, Alabama
  • +259 more
Jul 20, 2020

NSCLC Trial in Worldwide (Tislelizumab, Concurrent chemoradiotherapy (cCRT), Placebo)

Terminated
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Los Angeles, California
  • +163 more
Jun 26, 2020

NSCLC Trial in Seoul (CS-7017, Carboplatin, Paclitaxel)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Seoul, Gangnam-gu, Korea, Republic of
    Samsung Medical Center
Jun 23, 2020

NSCLC Trial in Worldwide (BI 695502, Avastin)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Anaheim, California
  • +188 more
Dec 26, 2019

NSCLC Trial in Worldwide (Emibetuzumab, Erlotinib)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Birmingham, Alabama
  • +58 more
Sep 6, 2019

NSCLC Trial in Worldwide (afatinib, erlotinib)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Chandler, Arizona
  • +191 more
Feb 8, 2019

NSCLC, Adenocarcinoma Trial in China, Korea, Republic of, Thailand (Gemcitabine+Cisplatin, BIBW 2992)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Adenocarcinoma
  • Beijing, China
  • +35 more
Dec 13, 2018

NSCLC Trial in Worldwide ( plus docetaxel, BIBF 1120 plus docetaxel)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • placebo plus docetaxel
  • BIBF 1120 plus docetaxel
  • Graz, Austria
  • +209 more
Nov 9, 2018

NSCLC Trial in Korea, Republic of (Afatinib)

Approved for marketing
  • Carcinoma, Non-Small-Cell Lung
  • Bucheon, Korea, Republic of
  • +7 more
Nov 12, 2018

NSCLC Trial in Worldwide (BI 836845, afatinib)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Fukuoka, Fukuoka, Japan
  • +9 more
Apr 30, 2018

NSCLC, Adenocarcinoma Trial in Worldwide (Pemetrexed, BIBW 2992, Cisplatin)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Adenocarcinoma
  • Fayetteville, Arkansas
  • +132 more
Mar 9, 2018

Non-Small-Cell Lung Cancer Stage IIIB, Non-Small-Cell Lung Cancer Stage IV, Non-Small-Cell Lung Cancer Metastatic Trial in

Completed
  • Non-Small-Cell Lung Cancer Stage IIIB
  • +6 more
  • bavituximab
  • +2 more
  • Huntsville, Alabama
  • +160 more
Apr 19, 2017

NSCLC Trial in Worldwide (Investigator´s choice of chemo, BIBW 2992)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Investigator´s choice of chemotherapy
  • BIBW 2992
  • Ciudad Autonoma de Buenos Aires, Argentina
  • +97 more
Feb 15, 2017

NSCLC Trial in Seoul (Cisplatin, Pemetrexed)

Unknown status
  • Carcinoma, Non-Small-Cell Lung
  • Seoul, Korea, Republic of
    Samsung Medical Center
Feb 9, 2017

NSCLC Trial in Worldwide (Nintedanib (BIBF1120), Pemetrexed, pemetrexed)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Nintedanib (BIBF1120)
  • +6 more
  • Downy, California
  • +166 more
Dec 8, 2016

NSCLC Trial in Worldwide (PF-02341066)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Birmingham, Alabama
  • +278 more
Nov 17, 2016

NSCLC Trial in Worldwide (PF-02341066, Pemetrexed, Docetaxel)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Little Rock, Arkansas
  • +263 more
Oct 31, 2016

NSCLC Trial in Worldwide (MM-121, Erlotinib)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Birmingham, Alabama
  • +37 more
Jul 12, 2016